At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Gabapentindrug
Likely dose
Gabapentin 300 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Gabapentin on Slow Wave Sleep in Adult Critically Ill Patient.
In Brief
A clinical study evaluating Gabapentin for Sleep Deprivation and Critically Ill. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The investigators proposed that gabapentin will increase slow-wave sleep in adult critically ill patients. Increasing slow-wave sleep will improve the patients' outcomes (shortening ICU length of stay, improving ventilator free days, increasing delirium free days) in critically ill patients, a university hospital, Thailand.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Deprivation, Critically Ill
CountriesThailand
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartApr 2021
Primary CompletionJun 2022
Study CompletionJul 2022
TodayJul 2026
First PostedMar 26, 2021
Enrollment StartApr 19, 2021
Primary CompletionJun 25, 2022
Study CompletionJul 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.3 years ago
Interventions
Gabapentindrug
Gabapentin 100-300 mg is given to the intervention group